Grasim's ₹17,200 cr bet, Biocon's Mylan exit, and ED arrests dominate

Grasim's ABRen is buying Shell's Sprng Energy for ₹17,200 cr — about 8% of Grasim's market cap and a step-change in its renewables ambition. With 9.3 GWp, ABRen becomes a top-tier clean energy platform overnight. The Global Infrastructure Partners backing adds execution credibility to a deal that reshapes the conglomerate's sum-of-parts story.

Mylan sold its entire 5.64% stake in Biocon for roughly ₹4,000 cr in an open-market transaction. For a stock trading at 175x trailing earnings with ROE under 5%, the full exit of a long-time biosimilar partner is a material overhang. The partnership dynamic is now uncertain at a time when Biocon needs all the credibility it can get.

Brigade Enterprises plans a ₹1,500 cr NCD issue, about 8.3% of its market cap and a quarter of FY26 revenue, while the promoter subscribes to warrants. The debt raise signals a funding push for expansion or refinancing, but it adds use to a balance sheet already at 0.94 debt/equity. The next test is deployment clarity.

Vikas EcoTech's promoter was arrested by the ED under PMLA — a severe governance event for a ₹171 cr nano-cap that already carried qualified audit opinions and a prior ED attachment. The company's reassurance does not remove the legal uncertainty or the risk to capital access. For a stock at 25x earnings with declining revenue, the credibility gap just widened.

Vikas Lifecare's promoter was also held by the ED, compounding a company already flagged for an ED attachment and FEMA lapses. At a ₹272 cr market cap, the promoter's arrest threatens credit relationships and strategic execution. The auditor's recent qualified opinion now reads as a prelude.

Ebix promoter Vikas Garg was arrested under PMLA, escalation from a prior ED attachment order. For a nano-cap already navigating restructuring, this introduces severe governance uncertainty. The company's ability to operate without a key individual is now the open question.

Lokesh Machines landed a ₹58 cr defence order for machine gun kits from the Indian Army — about 10% of its market cap and a validation of its manufacturing credentials after exiting US sanctions. For a micro-cap at 150x PE, this provides meaningful revenue visibility. The next test is repeat orders.

Innovision bagged a ₹205 cr NHAI toll contract, its biggest-ever and 30% of its market cap, pushing visible pipeline well above trailing quarterly revenue of ₹268 cr. The win signals growing NHAI confidence after a recent order correction. Execution over the contract term now matters.

Simplex Castings added ₹130 cr to its order book, now 64% of FY26 revenue, and secured SAIL as a fabrication partner. The short execution window and marquee repeats signal a credibility upgrade after a Q4 miss. The ₹431 cr market cap leaves room for re-rating if delivery holds.

AYE Finance eyes a ₹4,000 cr NCD raise, nearly its entire market cap, to expand its lending book. For a small-cap NBFC with debt/equity of 2.73, this would test its cost of capital and asset quality. The 28% AUM growth and easing GNPA are tailwinds, but use is the risk.

Wanbury redeemed ₹180 cr of NCDs five years early — a debt equal to 15% of its market cap — signalling strong liquidity and management confidence after a 117% profit jump. The early payoff sharply reduces interest outgo. For a micro-cap with a debt/equity of 2.92, this is a rare positive surprise.

Sigma Advanced Systems bought UK aerospace maker Bromford for ₹153 cr, adding 46% to consolidated revenue. The cash spend is modest against Sigma's ₹10,840 cr market cap, but the revenue impact is a step change. Deepening ties with OEMs is the strategic play.

Latent View's CEO quit suddenly, with an ex-Wipro exec taking over. The departure comes right after the company cut FY27 growth guidance to 12-13% from 30%. For a mid-cap at 31x PE, leadership vacuum compounds execution risk in a slowing business.

SBFC's co-founder CFO resigned; an internal successor was named. While the transition seems orderly, the departure of a co-founder at a mid-cap NBFC with recent borrowing limit expansion raises questions about management stability. The ₹10,057 cr market cap can absorb a leadership change, but the timing is sensitive.